Simon F Campbell

Deal, United Kingdom

Simon F Campbell

Average Co-Inventor Count = 2.5

ph-index = 13

Forward Citations = 530(Granted Patents)

Forward Citations (Not Self Cited) = 485(Sep 21, 2024)

Location History:

  • Kingsdown, Deal, GB (1987)
  • Deal, GB (1980 - 1990)
  • Kingsdown, GB (1983 - 1990)
  • Grey Friars, GB (1990)
  • Sandwich, GB (2000 - 2003)
  • Kent, GB (2015)
  • Poole, GB (2016 - 2023)


Years Active: 1980-2023

where 'Filed Patents' based on already Granted Patents

52 patents (USPTO):

Title: The Innovative Contributions of Simon F. Campbell

Introduction: Simon F. Campbell, a prominent inventor based in Deal, GB, has made significant strides in the field of pharmaceutical innovations. With a remarkable portfolio consisting of 46 patents, Campbell has established himself as a leading figure in the development of treatments aimed at addressing erectile dysfunction.

Latest Patents: Among Campbell's latest innovations are two notable patents. The first, titled "6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction," focuses on compounds that serve as selective inhibitors of cGMP phosphodiesterase (PDE). These compounds have shown potential in the treatment of erectile dysfunction (impotence) in male animals, including humans. The second patent, "Bicyclic heterocyclic compounds for the treatment of impotence," discusses the application of specific 6-arylpyrazolo[3,4-d]pyrimidin-4-ones, 2-arylquinazolin-4-ones, and other related compounds in creating medicaments for curative or prophylactic treatment of erectile dysfunction.

Career Highlights: Campbell has dedicated his career to advancing pharmaceutical research and development, particularly while working for Pfizer Corporation. His innovative work in medicinal chemistry has played a crucial role in providing new therapeutic options for patients suffering from erectile dysfunction.

Collaborations: Throughout his career, Simon F. Campbell has collaborated with esteemed colleagues, including Peter E. Cross and John K. Stubbs. Working alongside such talented professionals has facilitated a productive exchange of ideas and expertise, enhancing the outcome of their shared projects.

Conclusion: Simon F. Campbell's contributions to the field of pharmaceuticals exemplify the impact of innovation in healthcare. His extensive portfolio of patents highlights his commitment to finding effective treatments for erectile dysfunction, underscoring his role as a key innovator in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…